世界发展银行-Combating-Noncommunicable-Diseases-in-Kenya-_-An-Investment-Case_69页_1mb

Combating Noncommunicable Diseases in Kenya: An Investment Case Summary

Core Content

This report presents an investment case for combating noncommunicable diseases (NCDs) in Kenya, focusing on the economic burden and potential benefits of scaling up interventions. It highlights the urgent need for increased investment in NCD prevention and treatment to support Kenya's health reform agenda and its pursuit of Universal Health Coverage (UHC).

Main Objectives

The study aims to:

• Assess the current economic burden of NCDs in Kenya.
• Quantify the short- and medium-term economic benefits and costs of scaling up treatment interventions.
• Provide evidence to strengthen advocacy and resource mobilization for NCD prevention and control.

Key Findings

Economic Burden

• In 2016, NCDs caused KSh 230 billion in economic losses, equivalent to 3.4% of Kenya's GDP.
• 93% of the burden is due to indirect productivity losses, while the remaining 7% is from direct medical costs.
• By 2030, if current intervention coverage remains low, NCDs are projected to cause KSh 607 billion in annual economic losses.

Intervention Impact

• Scaling up screening and treatment for CVD, COPD, breast cancer, and cervical cancer could:
  • Avert nearly 110,000 incremental deaths, with CVD accounting for 89,000.
  • Restore 811,000 healthy life years, with COPD interventions contributing 67%.
• The return on investment (ROI) for these interventions is as follows:
  • CVD: ROI of 2.48
  • Cervical Cancer: ROI of 0.73
  • Breast Cancer: ROI of 0.57
  • COPD: ROI of 0.09

Cost-Benefit Analysis

• The economic benefits of scaling up interventions amount to KSh 175 billion, while the costs are KSh 142 billion.
• CVD interventions are the most economically efficient and offer the highest ROI.
• Cancer and COPD interventions have lower ROIs, but still offer significant health benefits.

Key Interventions and Risk Factors

Targeted NCDs and Injuries

• Cardiovascular Disease (CVD)
• Chronic Obstructive Pulmonary Disease (COPD)
• Breast Cancer
• Cervical Cancer
• Diabetes
• Road Traffic Injuries (RTI)
• Sickle Cell Disease

Major Risk Factors

• Tobacco smoking
• Unhealthy diet
• Physical inactivity
• Harmful alcohol consumption
• Metabolic risk factors: hypertension, hyperlipidemia, hyperglycemia, obesity

Policy Recommendations

1. Scale up interventions for NCDs, prioritizing those with the highest ROI, particularly CVD.
2. Increase NCD resource allocation by the Government of Kenya and other partners.
3. Prioritize prevention and health promotion to address modifiable risk factors.
4. Continue investment in NCD control through UHC to ensure equitable access and financial protection.
5. Plan additional economic analyses for diseases not included in the ROI analysis, such as diabetes and sickle cell disease, to provide a more comprehensive understanding.

Methodology

• The study uses a cost-of-illness approach to assess the economic burden, including direct and indirect costs.
• UN OneHealth Tool (OHT) is used to evaluate the health and economic benefits of scaling up interventions.
• Return on Investment (ROI) is calculated using the human capital approach.

Limitations and Future Work

• The study did not include diabetes, sickle cell disease, and road traffic injuries in the ROI analysis.
• Future work should include these diseases and conditions for a more complete picture.
• The ROI analysis did not account for reductions in disease morbidity, which may affect the prioritization of interventions.

Conclusion

The report underscores the importance of addressing NCDs to achieve UHC, promote human capital development, and support long-term economic growth. It provides a credible basis for investment decisions and highlights the need for political commitment and resource mobilization to combat NCDs effectively.